Share on LinkedInShare on LinkedIn

ARTICLE · 23 JANUARY 2023

USPTO Launches The Cancer Moonshot Expedited Examination Pilot Program

On February 1, 2023, the United States Patent & Trademark Office (USPTO) will begin accepting petitions to accelerate examination under the Cancer Moonshot Expedited Examination...

United StatesIntellectual Property

On February 1, 2023, the United States Patent & Trademark Office (USPTO) will begin accepting petitions to accelerate examination under the Cancer Moonshot Expedited Examination Pilot Program (the "Moonshot Program"). The Moonshot Program replaces and expands the current "Cancer Immunotherapy Pilot Program" (also called "Patents for Patients" or "P4P"). The Moonshot Program is scheduled to continue until the earlier of January 31, 2025 or until the USPTO has accepted 1,000 grantable petitions.

The Moonshot Program offers expedited examination of patent applications in the fields of oncology or smoking cessation that have an eligible method claim selected from:

  • Methods of treating cancer using an immunotherapy (as in the current P4P program).

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from